✦ LIBER ✦

The quantitation of cell surface antigens by antibody-complement mediated cytotoxicity: application to murine leukemia virus-infected mouse cells

✍ Scribed by J.E.T. Moen; J. Brouwer; S.O. Warnaar

Book ID: 118897652
Publisher: Elsevier Science
Year: 1979
Tongue: English
Weight: 374 KB
Volume: 31
Category: Article
ISSN: 0022-1759
DOI: 10.1016/0022-1759(79)90138-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Murine leukemia cell hybrids: The quanti

Murine leukemia cell hybrids: The quantity of TL antigens expressed by parental and hybrid cells fails to correlate with their sensitivity to TL antibody and complement

✍ Cohen, Edward P. ;Liang, Weitze 📂 Article 📅 1978 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 708 KB

## Abstract The quantity of thymus‐leukemia (TL) antigens expressed by murine leukemia cells is significantly greater than that expressed by somatic hybrids of such cells. Based upon the results of ^125^I‐lactoperoxidase labeling and antibody absorption procedures, and corrected for size difference

Dual susceptibility of a 3T3 mouse cell

Dual susceptibility of a 3T3 mouse cell line to infection by N- and B-tropic murine leukemia virus: Apparent lack of expression of the FV-1 gene

✍ S. Gisselbrecht; R. H. Bassin; B. I. Gerwin; A. Rein 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 French ⚖ 644 KB

## Abstract A murine sarcoma virus‐transformed S+L—3T3FL cell line has previously been shown to be equally susceptible to infection with both N‐ and B‐tropic variants of murine leukemia virus, unlike all other mouse cells so far described (Krontiris et al., 1973). Transformed S+L—‐BALB/3T3 and S+L‐

Biology of simian virus 40 (SV40) transp

Biology of simian virus 40 (SV40) transplantation antigen (TrAg): V. In vitro demonstration of SV40 TrAg in SV40 infected nonpermissive mouse cells by the lymphocyte mediated cytotoxicity assay

✍ Judith Pretell; Robert S. Greenfield; Satvir S. Tevethia 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 954 KB

Treatment of the P815 murine mastocytoma

Treatment of the P815 murine mastocytoma with cisplatin or etoposide up-regulates cell-surface Fas (CD95) expression and increases sensitivity to anti-Fas antibody-mediated cytotoxicity and to lysis by anti-CD3-activated killer-T cells

✍ Brent A. Williams; Andrew P. Makrigiannis; Jonathan Blay; David W. Hoskin 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 122 KB 👁 2 views

We have investigated the effect of pre-treatment with the anti-cancer drugs cisplatin and etoposide on the susceptibility of P815 murine mastocytoma cells to lysis by murine spleen-derived anti-CD3-activated killer-T (AK-T) cells. A 20 hr pre-treatment with cisplatin (0.2-2 microg/ml) or etoposide (